These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11023559)

  • 1. Medical therapy of steroid-resistant Crohn's disease.
    Sands BE
    Can J Gastroenterol; 2000 Sep; 14 Suppl C():33C-37C. PubMed ID: 11023559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid-dependent Crohn's disease.
    Sandborn WJ
    Can J Gastroenterol; 2000 Sep; 14 Suppl C():17C-22C. PubMed ID: 11023556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: chronic active disease and maintaining remission in Crohn's disease.
    Kamm MA
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():102-5. PubMed ID: 15352904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe and steroid-resistant Crohn's disease.
    Michetti P; Mottet C; Juillerat P; Felley C; Vader JP; Burnand B; Gonvers JJ; Froehlich F
    Digestion; 2005; 71(1):19-25. PubMed ID: 15711044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance therapy in Crohn's disease.
    Steinhart H
    Can J Gastroenterol; 2000 Sep; 14 Suppl C():23C-28C. PubMed ID: 11023557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcending conventional therapies: the role of biologic and other novel therapies.
    Sandborn WJ
    Inflamm Bowel Dis; 2001 May; 7 Suppl 1():S9-16. PubMed ID: 11380043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe and steroid-resistant Crohn's disease.
    Michetti P; Mottet C; Juillerat P; Pittet V; Felley C; Vader JP; Gonvers JJ; Froehlich F
    Digestion; 2007; 76(2):99-108. PubMed ID: 18239400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003459. PubMed ID: 15674908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: the limitations of corticosteroid therapy in Crohn's disease.
    Rutgeerts PJ
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1515-25. PubMed ID: 11563990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease.
    Gelbmann CM; Rogler G; Gross V; Gierend M; Bregenzer N; Andus T; Schölmerich J
    Am J Gastroenterol; 2002 Jun; 97(6):1438-45. PubMed ID: 12094862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2003; (1):CD003459. PubMed ID: 12535475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approach to corticosteroid-dependent and corticosteroid-refractory Crohn's disease.
    Lichtenstein GR
    Inflamm Bowel Dis; 2001 May; 7 Suppl 1():S23-9. PubMed ID: 11380040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild to moderate Crohn's disease: still room for step-up therapies?
    Bar-Meir S
    Dig Dis; 2009; 27(3):347-50. PubMed ID: 19786763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor necrosis factor agents reduce corticosteroid use compared with azathioprine in patients with Crohn's disease.
    Kane SV; Jaganathan S; Bedenbaugh AV; Palmer L; Schwartz DA
    Curr Med Res Opin; 2014 Sep; 30(9):1821-6. PubMed ID: 24884302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil in patients with Crohn's disease.
    Fickert P; Hinterleitner TA; Wenzl HH; Aichbichler BW; Petritsch W
    Am J Gastroenterol; 1998 Dec; 93(12):2529-32. PubMed ID: 9860419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Internistic therapy possibilities in therapy-resistant Crohn disease].
    Hoffmann R
    Schweiz Rundsch Med Prax; 1992 Jun; 81(26):866-8. PubMed ID: 1626163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-TNF therapy in treatment of luminal Crohn's disease].
    Marko B; Prka L
    Acta Med Croatica; 2013 Apr; 67(2):179-89. PubMed ID: 24471301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of remission in Crohn's disease.
    Gonvers JJ; Juillerat P; Mottet C; Felley C; Burnand B; Vader JP; Michetti P; Froehlich F
    Digestion; 2005; 71(1):41-8. PubMed ID: 15711049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.